ArticleJournal of translational medicine2024

CircDCAF8 promotes the progression of hepatocellular carcinoma through miR-217/NAP1L1 Axis, and induces angiogenesis and regorafenib resistance via exosome-mediated transfer.

Jiahao Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.